These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33433530)

  • 1. Testosterone, cardiomyopathies, and heart failure: a narrative review.
    Diaconu R; Donoiu I; Mirea O; Bălşeanu TA
    Asian J Androl; 2021; 23(4):348-356. PubMed ID: 33433530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart failure in pressure overload hypertrophy. The relative roles of ventricular remodeling and myocardial dysfunction.
    Norton GR; Woodiwiss AJ; Gaasch WH; Mela T; Chung ES; Aurigemma GP; Meyer TE
    J Am Coll Cardiol; 2002 Feb; 39(4):664-71. PubMed ID: 11849866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressure overload hypertrophy and congestive heart failure. Where is the "Achilles' heel"?
    Peterson KL
    J Am Coll Cardiol; 2002 Feb; 39(4):672-5. PubMed ID: 11849867
    [No Abstract]   [Full Text] [Related]  

  • 4. Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial.
    Ravassa S; Trippel T; Bach D; Bachran D; González A; López B; Wachter R; Hasenfuss G; Delles C; Dominiczak AF; Pieske B; Díez J; Edelmann F
    Eur J Heart Fail; 2018 Sep; 20(9):1290-1299. PubMed ID: 29709099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential usefulness of serum melatonin level to predict heart failure in patients with hypertensive cardiomyopathy.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Reiter RJ
    Int J Cardiol; 2014 Jun; 174(2):415-7. PubMed ID: 24768380
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of LV systolic dyssynchrony in heart failure beyond a snapshot.
    Yu CM; Zhang Q
    JACC Cardiovasc Imaging; 2011 May; 4(5):457-9. PubMed ID: 21565731
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic performance of BNP and NT-ProBNP measurements in children with heart failure based on congenital heart defects and cardiomyopathies.
    Şahin M; Portakal O; Karagöz T; Hasçelik G; Özkutlu S
    Clin Biochem; 2010 Nov; 43(16-17):1278-81. PubMed ID: 20709045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation as manifestation and consequence of underlying cardiomyopathies: from common conditions to genetic diseases.
    Mohmand-Borkowski A; Tang WH
    Heart Fail Rev; 2014 May; 19(3):295-304. PubMed ID: 24531802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late gadolinium enhancement on cardiac magnetic resonance predicts coronary vasomotor abnormality and myocardial lactate production in patients with chronic heart failure.
    Uemura T; Yamamuro M; Kaikita K; Takashio S; Utsunomiya D; Hirakawa K; Nakayama M; Sakamoto K; Yamamoto E; Tsujita K; Kojima S; Hokimoto S; Yamashita Y; Ogawa H
    Heart Vessels; 2016 Dec; 31(12):1969-1979. PubMed ID: 26892530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity Cardiomyopathy: Pathophysiologic Factors and Nosologic Reevaluation.
    Bhatheja S; Panchal HB; Ventura H; Paul TK
    Am J Med Sci; 2016 Aug; 352(2):219-22. PubMed ID: 27524223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and Cardiac Galectin-3 in Patients With Heart Failure Reflects Both Inflammation and Fibrosis: Implications for Its Use as a Biomarker.
    Besler C; Lang D; Urban D; Rommel KP; von Roeder M; Fengler K; Blazek S; Kandolf R; Klingel K; Thiele H; Linke A; Schuler G; Adams V; Lurz P
    Circ Heart Fail; 2017 Mar; 10(3):. PubMed ID: 28288987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of infiltrative cardiomyopathies resulting in heart failure with preserved ejection fraction.
    Madan N; Kalra D
    Rev Cardiovasc Med; 2020 Jun; 21(2):181-190. PubMed ID: 32706207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 myocarditis and prospective heart failure burden.
    Shchendrygina A; Nagel E; Puntmann VO; Valbuena-Lopez S
    Expert Rev Cardiovasc Ther; 2021 Jan; 19(1):5-14. PubMed ID: 33119418
    [No Abstract]   [Full Text] [Related]  

  • 15. A heart with red flags.
    Oliveira CC; Pereira VH; Rodrigues C; Vieira C; Salgado A
    Int J Cardiovasc Imaging; 2020 Sep; 36(9):1749-1750. PubMed ID: 32394179
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of Myocarditis-Related Cardiomyopathy in Adults.
    Tschöpe C; Cooper LT; Torre-Amione G; Van Linthout S
    Circ Res; 2019 May; 124(11):1568-1583. PubMed ID: 31120823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of myofilament cross-bridge kinetic in the heart of orchidectomized rats.
    Wadthaisong M; Wattanapermpool J; de Tombe PP; Bupha-Intr T
    Life Sci; 2020 Nov; 261():118342. PubMed ID: 32853655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Histological and ultrastructural characteristics of myocardium in heart failure].
    Tsyplenkova VG
    Kardiologiia; 2013; 53(9):52-5. PubMed ID: 24090387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSP60 in heart failure: abnormal distribution and role in cardiac myocyte apoptosis.
    Lin L; Kim SC; Wang Y; Gupta S; Davis B; Simon SI; Torre-Amione G; Knowlton AA
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2238-47. PubMed ID: 17675567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clarification of the cardiomyopathies.
    Goodwin JE
    Mod Concepts Cardiovasc Dis; 1972 Sep; 41(9):41-6. PubMed ID: 4404228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.